Breaking

Pascal Geldsetzer, an epidemiologist from Stanford University, recently conducted a groundbreaking study that explores the potential link between chickenpox, shingles, and Alzheimer's disease. Despite his belief in open access to scientific information, Geldsetzer hesitated...

Amgen, Biogen, and Takeda are three biopharma companies facing challenges in developing treatments for obesity and Alzheimer's disease. At the STAT 2024 Summit in Boston, leaders from these companies discussed their research and development...

Alnylam Pharmaceuticals, led by CEO Yvonne Greenstreet, is making strides in expanding the use of its RNA-based gene-silencing heart drug, vutrisiran. The drug has shown promising results in reducing the risk of death and...

As the week comes to a close, many of us are looking forward to the weekend and making plans to relax and unwind. Here at Pharmalot, we are preparing to tidy up our campus,...

Health care is a significant topic in the upcoming U.S. election, with leaders from different political backgrounds sharing their views on various health care issues at STAT's Summit. Among the topics discussed were Medicare,...

I’m recovering from the STAT Summit — in particular, recovering from this stunning view of Boston from the venue. On Wednesday evening, we had an amazing view of the almost-supermoon rising as dusk settled...

Robert F. Kennedy Jr.'s recent rise in the political arena has sparked concerns among health leaders and GOP members. Kennedy's potential involvement in a winning president's team and his aspirations for a top health...

Prescription drug sales in the United States through a government discount program called the 340B Drug Discount Program reached a whopping $63 billion in 2023. This is a significant 23.4% increase from the previous...

Are you excited about hiring someone new or promoting a rising star in your company? Maybe you finally filled that hard-to-fill spot? Well, we want to hear about it! Share your news with us,...

CVS Health recently made a significant change in its leadership by appointing David Joyner as the new CEO, replacing Karen Lynch. This decision comes as the company faces challenges and aims to improve its...

Medicare is facing some challenges, and a former official, Donald Berwick, blames the Medicare Advantage program run by private insurers. Over half of Medicare beneficiaries are enrolled in Medicare Advantage plans, and this number...

A group of organizations, including labor unions and consumer advocates, is calling on the Federal Trade Commission to block the acquisition of Catalent, a major contract drug manufacturer, by Novo Nordisk’s parent foundation for...